Article Text

PDF
Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson’s disease cohort
  1. C H Williams-Gray1,
  2. A Goris2,3,
  3. T Foltynie1,
  4. J Brown1,
  5. M Maranian2,
  6. A Walton2,
  7. D A S Compston2,
  8. S J Sawcer2,
  9. R A Barker1
  1. 1Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, UK
  2. 2Neurology Unit, Department of Clinical Neurosciences, University of Cambridge, UK
  3. 3Laboratory for Clinical and Experimental Neurology, Katholieke Universiteit Leuven, Belgium
  1. Correspondence to:
 Dr C Williams-Gray
 Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 2PY, UK; chm27{at}cam.ac.uk

Abstract

The LRRK2 G2019S mutation is the commonest genetic cause of Parkinson’s disease (PD) identified to date, although estimates of its prevalence in idiopathic disease vary considerably. Our objectives were to determine G2019S mutation frequency in an unselected, community based cohort of idiopathic PD cases from the UK and to describe phenotypic characteristics among carriers. The mutation was present in two of 519 cases (0.4%) and none of 887 control individuals. The true prevalence of the mutation in idiopathic disease, its penetrance, and the phenotypic heterogeneity of associated cases have important implications for genetic screening in the clinical field.

Statistics from Altmetric.com

Footnotes

  • Competing interests: none declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.